Literature DB >> 25283091

Non-specific interaction of carbon nanotubes with the resazurin assay reagent: impact on in vitro assessment of nanoparticle cytotoxicity.

Dalibor Breznan1, Dharani Das2, Christine MacKinnon-Roy3, Benoit Simard4, Premkumari Kumarathasan2, Renaud Vincent3.   

Abstract

In vitro cytotoxicity assays are essential tools in the screening of engineered nanomaterials (NM) for cellular toxicity. The resazurin live cell assay is widely used because it is non-destructive and is well suited for high-throughput platforms. However, NMs, in particular carbon nanotubes (CNT) can interfere in assays through quenching of transmitted light or fluorescence. We show that using the resazurin assay with time-point reading of clarified supernatants resolves this problem. Human lung epithelial (A549) and murine macrophage (J774A.1) cell lines were exposed to NMs in 96-well plates in 200 μL of media/well. After 24 h incubation, 100 μL of supernatant was removed, replaced with resazurin reagent in culture media and aliquots at 10 min and 120 min were transferred to black-wall 96-well plates. The plates were quick-spun to sediment the residual CNTs and fluorescence was top-read (λEx=540 nm, λEm=600 nm). The procedure was validated for CNTs as well as silica nanoparticles (SiNP). There was no indication of reduction of resazurin by the CNTs. Stability of resorufin, the fluorescent product of the resazurin reduction was then assessed. We found that polar CNTs could decrease the fluorescence signal for resorufin, possibly through oxidation to resazurin or hyper-reduction to hydroxyresorufin. This effect can be easily quantified for elimination of the bias. We recommend that careful consideration must be given to fluorimetric/colorimetric in vitro toxicological assessments of optically/chemically active NMs in order to relieve any potential artifacts due to the NMs themselves. Crown
Copyright © 2014. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Carbon nanotubes; Cell viability; Cytotoxicity; In vitro; Interaction; Resazurin

Mesh:

Substances:

Year:  2014        PMID: 25283091     DOI: 10.1016/j.tiv.2014.09.009

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  6 in total

1.  Evaluation of CdTe/CdS/ZnS core/shell/shell quantum dot toxicity on three-dimensional spheroid cultures.

Authors:  Mehriban Ulusoy; Antonina Lavrentieva; Johanna-Gabriela Walter; Franziska Sambale; Mark Green; Frank Stahl; Thomas Scheper
Journal:  Toxicol Res (Camb)       Date:  2015-08-07       Impact factor: 3.524

Review 2.  Current Challenges toward In Vitro Cellular Validation of Inorganic Nanoparticles.

Authors:  Malou Henriksen-Lacey; Susana Carregal-Romero; Luis M Liz-Marzán
Journal:  Bioconjug Chem       Date:  2016-10-19       Impact factor: 4.774

Review 3.  A Review of Methods to Determine Viability, Vitality, and Metabolic Rates in Microbiology.

Authors:  Olivier Braissant; Monika Astasov-Frauenhoffer; Tuomas Waltimo; Gernot Bonkat
Journal:  Front Microbiol       Date:  2020-11-17       Impact factor: 5.640

4.  Bacterial Surface Disturbances Affecting Cell Function during Exposure to Three-Compound Nanocomposites Based on Graphene Materials.

Authors:  Agata Lange; Ewa Sawosz; Karolina Daniluk; Mateusz Wierzbicki; Artur Małolepszy; Marcin Gołębiewski; Sławomir Jaworski
Journal:  Nanomaterials (Basel)       Date:  2022-09-02       Impact factor: 5.719

5.  Development of an integrated approach for comparison of in vitro and in vivo responses to particulate matter.

Authors:  Dalibor Breznan; Subramanian Karthikeyan; Marcelle Phaneuf; Prem Kumarathasan; Sabit Cakmak; Michael S Denison; Jeffrey R Brook; Renaud Vincent
Journal:  Part Fibre Toxicol       Date:  2016-08-12       Impact factor: 9.400

6.  High time resolution and high signal-to-noise monitoring of the bacterial growth kinetics in the presence of plasmonic nanoparticles.

Authors:  Marija Vukomanovic; Eduard Torrents
Journal:  J Nanobiotechnology       Date:  2019-02-01       Impact factor: 10.435

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.